Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Converting p53 from a killer into a healer

Nature Medicine volume 8, pages 1196–1198 (2002)Cite this article

Selenium-containing compounds are in phase 2 and 3 clinical trials for prostate cancer prevention, although it is unclear how they work. A study suggests that selenium can facilitate DNA repair by activating the p53 tumor suppressor in an unusual way.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Selenium and p53.

References

  1. Nelson, M.A., Porterfield, B.W., Jacobs, E.T. & Clark, L.C. Semin. Urol. Oncol. 17, 91–96 (1999).

    CAS  PubMed  Google Scholar 

  2. Seo, Y.R., Kelley, M., Smith, M L. Selenomethionine regulation of p53 by a ref-1-dependent redox mechanism. Proc. Natl. Acad. Sci. USA; published online September 30, 2002, doi:qo.qo73/pnas.212319799.

  3. Bernstein, C., Bernstein, H., Payne, C.M. & Garewal, H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: Fail-safe protection against carcinogenesis. Mutat. Res. 511, 145–78 (2002).

    Article  CAS  Google Scholar 

  4. Prives, C. & Hall, P.A. The p53 pathway. J. Pathol. 187, 112–26 (1999).

    Article  CAS  Google Scholar 

  5. Vousden, K.H. & Lu, X. Live or let die: The cell's response to p53. Nat. Rev. Cancer 2, 594–604 (2002).

    Article  CAS  Google Scholar 

  6. Lane, D.P. & Lain, S. Therapeutic exploitation of the p53 pathway. Trends Mol. Med. 4, S38–42 (2002).

    Article  Google Scholar 

  7. Komarov, P.G. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733–1737 (1999).

    Article  CAS  Google Scholar 

  8. Bykov, V.J. et al. Restoration of the tumor suppressor function to p53 by a low-molecular-weight compound. Nature Med. 3, 282–288 (2002).

    Article  Google Scholar 

  9. Foster, B.A., Coffey, H.A., Morin, M.J. & Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507–2510 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Biology Lerner Research Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Andrei V. Gudkov

Authors
  1. Andrei V. Gudkov
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gudkov, A. Converting p53 from a killer into a healer. Nat Med 8, 1196–1198 (2002). https://doi.org/10.1038/nm1102-1196

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1102-1196

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing